一个案例报告关于177路-PSMA治疗转移性前列腺癌的戏剧性反应

相关实验视频

Updated: Aug 1, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.3K

Aysenur Sinem Erdogan1, Haluk Sayan2, Bedri Seven3

  • 1Department of Nuclear Medicine, Ankara City Hospital, University of Health Sciences, Ankara, Turkey.

Current medical imaging
|July 22, 2025
PubMed
概括

标有卢-177的前列腺特异性膜抗原 (Lu-PSMA) 治疗对转移性割抵抗性前列腺癌显示出有前途的结果. 早期服用和保存骨髓储备可能会改善治疗结果.

关键词:
177Lu-PSMAMA 没有任何问题.转移性抵抗割的前列腺癌.前列腺癌是什么意思 前列腺癌是什么意思前列腺特异性膜抗原.放射性合物治疗是一种放射性合物治疗.超神主义者. 超神主义者.

更多相关视频

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.3K
A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

10.1K

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...